The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease
Approximately 50% of colorectal cancer patients will develop metastases during the course of the disease. Local or locoregional therapies for the treatment of liver metastases are used in the management of oligometastatic colorectal liver disease, especially in nonsurgical candidates. Thermal ablati...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/2/308 |
id |
doaj-ea61b48f6c98432383dcf1d2798af57a |
---|---|
record_format |
Article |
spelling |
doaj-ea61b48f6c98432383dcf1d2798af57a2021-02-15T00:03:37ZengMDPI AGDiagnostics2075-44182021-02-011130830810.3390/diagnostics11020308The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic DiseaseDimitrios K. Filippiadis0Georgios Velonakis1Alexis Kelekis2Constantinos T. Sofocleous32nd Department of Radiology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, Athens 12462, Greece2nd Department of Radiology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, Athens 12462, Greece2nd Department of Radiology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, Athens 12462, GreeceMemorial Sloan Kettering Cancer Center, Weill-Cornell Medical College, New York, NY 10065, USAApproximately 50% of colorectal cancer patients will develop metastases during the course of the disease. Local or locoregional therapies for the treatment of liver metastases are used in the management of oligometastatic colorectal liver disease, especially in nonsurgical candidates. Thermal ablation (TA) is recommended in the treatment of limited liver metastases as free-standing therapy or in combination with surgery as long as all visible disease can be eradicated. Percutaneous TA has been proven as a safe and efficacious therapy offering sustained local tumor control and improved patient survival. Continuous technological advances in diagnostic imaging and guidance tools, the evolution of devices allowing for optimization of ablation parameters, as well as the ability to perform margin assessment have improved the efficacy of ablation. This allows resectable small volume diseases to be cured with percutaneous ablation. The ongoing detailed information and increasing understanding of tumor biology, genetics, and tissue biomarkers that impact oncologic outcomes as well as their implications on the results of ablation have further allowed for treatment customization and improved oncologic outcomes even in those with more aggressive tumor biology. The purpose of this review is to present the most common indications for image-guided percutaneous ablation in colorectal cancer liver metastases, to describe technical considerations, and to discuss relevant peer-reviewed evidence on this topic. The growing role of imaging and image-guidance as well as controversies regarding several devices are addressed.https://www.mdpi.com/2075-4418/11/2/308ablation techniquesliver ablationcolorectal cancerhepatic metastasisinterventional oncologythermal ablation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dimitrios K. Filippiadis Georgios Velonakis Alexis Kelekis Constantinos T. Sofocleous |
spellingShingle |
Dimitrios K. Filippiadis Georgios Velonakis Alexis Kelekis Constantinos T. Sofocleous The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease Diagnostics ablation techniques liver ablation colorectal cancer hepatic metastasis interventional oncology thermal ablation |
author_facet |
Dimitrios K. Filippiadis Georgios Velonakis Alexis Kelekis Constantinos T. Sofocleous |
author_sort |
Dimitrios K. Filippiadis |
title |
The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease |
title_short |
The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease |
title_full |
The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease |
title_fullStr |
The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease |
title_full_unstemmed |
The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease |
title_sort |
role of percutaneous ablation in the management of colorectal cancer liver metastatic disease |
publisher |
MDPI AG |
series |
Diagnostics |
issn |
2075-4418 |
publishDate |
2021-02-01 |
description |
Approximately 50% of colorectal cancer patients will develop metastases during the course of the disease. Local or locoregional therapies for the treatment of liver metastases are used in the management of oligometastatic colorectal liver disease, especially in nonsurgical candidates. Thermal ablation (TA) is recommended in the treatment of limited liver metastases as free-standing therapy or in combination with surgery as long as all visible disease can be eradicated. Percutaneous TA has been proven as a safe and efficacious therapy offering sustained local tumor control and improved patient survival. Continuous technological advances in diagnostic imaging and guidance tools, the evolution of devices allowing for optimization of ablation parameters, as well as the ability to perform margin assessment have improved the efficacy of ablation. This allows resectable small volume diseases to be cured with percutaneous ablation. The ongoing detailed information and increasing understanding of tumor biology, genetics, and tissue biomarkers that impact oncologic outcomes as well as their implications on the results of ablation have further allowed for treatment customization and improved oncologic outcomes even in those with more aggressive tumor biology. The purpose of this review is to present the most common indications for image-guided percutaneous ablation in colorectal cancer liver metastases, to describe technical considerations, and to discuss relevant peer-reviewed evidence on this topic. The growing role of imaging and image-guidance as well as controversies regarding several devices are addressed. |
topic |
ablation techniques liver ablation colorectal cancer hepatic metastasis interventional oncology thermal ablation |
url |
https://www.mdpi.com/2075-4418/11/2/308 |
work_keys_str_mv |
AT dimitrioskfilippiadis theroleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease AT georgiosvelonakis theroleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease AT alexiskelekis theroleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease AT constantinostsofocleous theroleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease AT dimitrioskfilippiadis roleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease AT georgiosvelonakis roleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease AT alexiskelekis roleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease AT constantinostsofocleous roleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease |
_version_ |
1724269347732455424 |